Urinary MicroRNAs of Prostate Cancer: Virus-Encoded hsv1-miRH18 and hsv2-miR-H9-5p Could Be Valuable Diagnostic Markers
Seok Joong Yun, Pildu Jeong, Ho Won Kang, Ye-Hwan Kim, Eun-Ah Kim, Chunri Yan, Young-Ki Choi, Dongho Kim, Jung Min Kim, Seon-Kyu Kim, Seon-Young Kim, Sang Tae Kim, Won Tae Kim, Ok-Jun Lee, Gou-Young Koh, Sung-Kwon Moon, Isaac Yi Kim, Jayoung Kim, Yung-Hyun Choi, Wun-Jae Kim
Int Neurourol J. 2015;19(2):74-84.   Published online 2015 Jun 29     DOI: https://doi.org/10.5213/inj.2015.19.2.74
Citations to this article as recorded by Crossref logo
Bacterial Peptides and Bacteriocins as Novel Treatment for Prostate Cancer
Keng Ye, Zunjin Ke, Xijiong Zhang, Ke Liang, Qi Zhang, Jianhong Huang
International Journal of Peptide Research and Therapeutics.2023;[Epub]     CrossRef
MicroRNAs as molecular biological markers of benign hyperplasia and prostate cancer differentiation
Z. M. Akhokhov, R. S. Ismailov, M. I. Kogan
Urology Herald.2023; 11(3): 98.     CrossRef
Herpes Simplex Virus 1 MicroRNAs: An Update
Yongzhong Duan, Le Sun, Qihan Li
Intervirology.2023; : 97.     CrossRef
Potential of miRNAs in urinary extracellular vesicles for management of active surveillance in prostate cancer patients
Manuel Ramirez-Garrastacho, Viktor Berge, Aija Linē, Alicia Llorente
British Journal of Cancer.2022; 126(3): 492.     CrossRef
Urinary hsv2-miR-H9 to hsa-miR-3659 ratio is an effective marker for discriminating prostate cancer from benign prostate hyperplasia in patients within the prostate-specific antigen grey zone
Ho Won Kang, Young Joon Byun, Sung Min Moon, Kyeong Kim, Xuan-Mei Piao, Chuang-Ming Zheng, Sung-Kwon Moon, Yung Hyun Choi, Won Tae Kim, Yong-June Kim, Sang-Cheol Lee, Seok Joong Yun, Wun-Jae Kim
Investigative and Clinical Urology.2022; 63(2): 238.     CrossRef
Neuronal miR-138 Represses HSV-2 Lytic Infection by Regulating Viral and Host Genes with Mechanistic Differences from HSV-1
Siyu Chen, Yue Deng, Hongjia Chen, Yuqi Lin, Xuewei Yang, Boqiang Sun, Dongli Pan, Jae U. Jung
Journal of Virology.2022;[Epub]     CrossRef
The Urobiome and Its Role in Overactive Bladder
Sangrak Bae, Hong Chung
International Neurourology Journal.2022; 26(3): 190.     CrossRef
The role of microRNA in the diagnosis of prostate cancer
D. R. Dolotkazin, M. Yu. Shkurnikov, B. Ya. Alekseev
Cancer Urology.2021; 16(4): 172.     CrossRef
Urinary microRNA-1913 to microRNA-3659 expression ratio as a non-invasive diagnostic biomarker for prostate cancer
Young Joon Byun, Xuan-Mei Piao, Pildu Jeong, Ho Won Kang, Sung Phil Seo, Sung-Kwon Moon, Jong-Young Lee, Yung Hyun Choi, Hee Youn Lee, Won Tae Kim, Sang-Cheol Lee, Eun-Jong Cha, Seok Joong Yun, Wun-Jae Kim
Investigative and Clinical Urology.2021; 62(3): 340.     CrossRef
Human herpesvirus-encoded MicroRNA in host-pathogen interaction
Araceli Valverde, Alexandra Seal, Salvador Nares, Deepak Shukla, Afsar Raza Naqvi
Advances in Biological Regulation.2021; 82: 100829.     CrossRef
Prostate Microbiota and Prostate Cancer: A New Trend in Treatment
Bangwei Che, Wenjun Zhang, Shenghan Xu, Jingju Yin, Jun He, Tao Huang, Wei Li, Ying Yu, Kaifa Tang
Frontiers in Oncology.2021;[Epub]     CrossRef
Non-coding RNAs as biomarkers in liquid biopsies with a special emphasis on extracellular vesicles in urological malignancies
Philip Zeuschner, Johannes Linxweiler, Kerstin Junker
Expert Review of Molecular Diagnostics.2020; 20(2): 151.     CrossRef
Human alpha and beta herpesviruses and cancer: passengers or foes?
František Golais, Veronika Mrázová
Folia Microbiologica.2020; 65(3): 439.     CrossRef
Liquid Biopsy to Detect DNA/RNA Based Markers of Small DNA Oncogenic Viruses for Prostate Cancer Diagnosis, Prognosis, and Prediction
Maurizio Provenzano, Abdou Kamal Allayeh
Frontiers in Oncology.2020;[Epub]     CrossRef

Biomarkers That Differentiate Benign Prostatic Hyperplasia from Prostate Cancer: A Literature Review

Christopher J McNally, Mark W Ruddock, Tara Moore, Declan J McKenna
Cancer Management and Research.2020; Volume 12: 5225.     CrossRef
The Potential Role of MicroRNAs as Biomarkers in Benign Prostatic Hyperplasia: A Systematic Review and Meta-analysis
Francesco Greco, Antonino Inferrera, Roberto La Rocca, Michele Navarra, Marco Casciaro, Gaetano Grosso, Sebastiano Gangemi, Vincenzo Ficarra, Vincenzo Mirone
European Urology Focus.2019; 5(3): 497.     CrossRef
Urinary cell‐free microRNA biomarker could discriminate bladder cancer from benign hematuria
Xuan‐Mei Piao, Pildu Jeong, Ye‐Hwan Kim, Young Joon Byun, Yanjie Xu, Ho Won Kang, Yun‐Sok Ha, Won Tae Kim, Jong‐Young Lee, Seung Hwo Woo, Tae Gyun Kwon, Isaac Y. Kim, Sung‐Kwon Moon, Yung Hyun Choi, Eun‐Jong Cha, Seok Joong Yun, Wun‐Jae Kim
International Journal of Cancer.2019; 144(2): 380.     CrossRef
Elevated miR-615-3p Expression Predicts Adverse Clinical Outcome and Promotes Proliferation and Migration of Prostate Cancer Cells
Emma B. Laursen, Jacob Fredsøe, Linnéa Schmidt, Siri H. Strand, Helle Kristensen, Anne K.I. Rasmussen, Tina F. Daugaard, Peter Mouritzen, Søren Høyer, Gitte Kristensen, Hein V. Stroomberg, Klaus Brasso, Martin Andreas Røder, Michael Borre, Karina D. Søren
The American Journal of Pathology.2019; 189(12): 2377.     CrossRef
Independent Validation of a Diagnostic Noninvasive 3-MicroRNA Ratio Model (uCaP) for Prostate Cancer in Cell-Free Urine
Jacob Fredsøe, Anne K I Rasmussen, Emma B Laursen, Yunpeng Cai, Kenneth A Howard, Bodil G Pedersen, Michael Borre, Peter Mouritzen, Torben Ørntoft, Karina D Sørensen
Clinical Chemistry.2019; 65(4): 540.     CrossRef
HSV1 latent transcription and non-coding RNA: A critical retrospective
Dane Phelan, Enrico R. Barrozo, David C. Bloom
Journal of Neuroimmunology.2017; 308: 65.     CrossRef
Beyond circulating microRNA biomarkers: Urinary microRNAs in ovarian and breast cancer
Maria Luisa Gasparri, Assunta Casorelli, Erlisa Bardhi, Aris Raad Besharat, Delia Savone, Ilary Ruscito, Ammad Ahmad Farooqi, Andrea Papadia, Michael David Mueller, Elisabetta Ferretti, Pierluigi Benedetti Panici
Tumor Biology.2017; 39(5): 101042831769552.     CrossRef
Urinary microRNAs for prostate cancer diagnosis, prognosis, and treatment response: are we there yet?
Ovidiu Balacescu, Bogdan Petrut, Oana Tudoran, Dragos Feflea, Loredana Balacescu, Andrei Anghel, Ioan O. Sirbu, Edward Seclaman, Catalin Marian
WIREs RNA.2017;[Epub]     CrossRef
Urinary RNA-based biomarkers for prostate cancer detection
Filippo Martignano, Lorena Rossi, Antonio Maugeri, Valentina Gallà, Vincenza Conteduca, Ugo De Giorgi, Valentina Casadio, Giuseppe Schepisi
Clinica Chimica Acta.2017; 473: 96.     CrossRef
miRNAs as novel biomarkers in the management of prostate cancer
Xavier Filella, Laura Foj
Clinical Chemistry and Laboratory Medicine (CCLM).2017;[Epub]     CrossRef
MiR-378 suppresses prostate cancer cell growth through downregulation of MAPK1 in vitro and in vivo
Qi-guang Chen, Wei Zhou, Tao Han, Shu-qi Du, Zhen-hua Li, Zhe Zhang, Guang-yi Shan, Chui-ze Kong
Tumor Biology.2016; 37(2): 2095.     CrossRef
miR-H28 and miR-H29 expressed late in productive infection are exported and restrict HSV-1 replication and spread in recipient cells
Zhiyuan Han, Xianjie Liu, Xiaoqing Chen, Xusha Zhou, Te Du, Bernard Roizman, Guoying Zhou
Proceedings of the National Academy of Sciences.2016;[Epub]     CrossRef
Urinary proteomics and metabolomics studies to monitor bladder health and urological diseases
Zhaohui Chen, Jayoung Kim
BMC Urology.2016;[Epub]     CrossRef
Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review
Edgars Endzeliņš, Vita Melne, Zane Kalniņa, Vilnis Lietuvietis, Una Riekstiņa, Alicia Llorente, Aija Linē
Molecular Cancer.2016;[Epub]     CrossRef
Increased Expression of Herpes Virus-Encoded hsv1-miR-H18 and hsv2-miR-H9-5p in Cancer-Containing Prostate Tissue Compared to That in Benign Prostate Hyperplasia Tissue
Seok Joong Yun, Pildu Jeong, Ho Won Kang, Helen Ki Shinn, Ye-Hwan Kim, Chunri Yan, Young-Ki Choi, Dongho Kim, Dong Hee Ryu, Yun-Sok Ha, Tae-Hwan Kim, Tae Gyun Kwon, Jung Min Kim, Sang Heon Suh, Seon-Kyu Kim, Seon-Young Kim, Sang Tae Kim, Won Tae Kim, Ok-J
International Neurourology Journal.2016; 20(2): 122.     CrossRef
The utility of urine-circulating miRNAs for detection of prostate cancer
Kristina Stuopelyte, Kristina Daniunaite, Arnas Bakavicius, Juozas R Lazutka, Feliksas Jankevicius, Sonata Jarmalaite
British Journal of Cancer.2016; 115(6): 707.     CrossRef
HSV1 MicroRNA Modulation of GPI Anchoring and Downstream Immune Evasion
Jonatan Enk, Assi Levi, Yiska Weisblum, Rachel Yamin, Yoav Charpak-Amikam, Dana G. Wolf, Ofer Mandelboim
Cell Reports.2016; 17(4): 949.     CrossRef
The translational potential of microRNAs as biofluid markers of urological tumours
Annika Fendler, Carsten Stephan, George M. Yousef, Glen Kristiansen, Klaus Jung
Nature Reviews Urology.2016; 13(12): 734.     CrossRef
Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling
Helle Kristensen, Anni R. Thomsen, Christa Haldrup, Lars Dyrskjøt, Søren Høyer, Michael Borre, Peter Mouritzen, Torben F. Ørntoft, Karina Dalsgaard Sørensen
Oncotarget.2016; 7(21): 30760.     CrossRef
UBE2C cell-free RNA in urine can discriminate between bladder cancer and hematuria
Won Tae Kim, Pildu Jeong, Chunri Yan, Ye Hwan Kim, Il-Seok Lee, Ho-Won Kang, Yong-June Kim, Sang-Cheol Lee, Sang Jin Kim, Yong Tae Kim, Sung-Kwon Moon, Yung-Hyun Choi, Isaac Yi Kim, Seok Joong Yun, Wun-Jae Kim
Oncotarget.2016; 7(36): 58193.     CrossRef
Virus encoded circulatory miRNAs for early detection of prostate cancer
Jayoung Kim, Seok Joong Yun, Wun-Jae Kim
BMC Urology.2015;[Epub]     CrossRef
MicroRNAs in the Cholangiopathies: Pathogenesis, Diagnosis, and Treatment
Maria Pisarello, Lorena Loarca, Tommy Ivanics, Leslie Morton, Nicholas LaRusso
Journal of Clinical Medicine.2015; 4(9): 1688.     CrossRef